Hanno Glimm
Medical oncologist who co-directs NCT/UCC Dresden and co-leads the NCT/DKFZ MASTER precision oncology programme for rare and young-onset cancers.
Overview
Hanno Glimm is a Managing Director of the National Center for Tumor Diseases (NCT/UCC) Dresden and heads its Department of Translational Medical Oncology. He co-leads the NCT/DKFZ MASTER programme, which applies whole-genome and transcriptome sequencing to guide treatment of patients with rare cancers and younger adults, and has published on hereditary cancer predisposition detected through comprehensive genomic profiling. His role is listed on the NCT/UCC Direktorium page.
Pages like this
not linked directly; found by shared links- PersonJürgen Weitz
Shares NCT/UCC Dresden – University Hospital Carl Gustav Carus and the tags leadership, clinician-scientist.
- PersonMartin Bornhäuser
Shares NCT/UCC Dresden – University Hospital Carl Gustav Carus and the tags leadership, clinician-scientist.
- PersonChristian Brandts
Shares the tags leadership, clinician-scientist, precision oncology.
- PersonJames Brenton
Shares the tags leadership, clinician-scientist, cancer genomics.
- PersonKjetil Taskén
Shares the tags leadership, clinician-scientist, precision oncology.
- PersonShivaani Kummar
Shares the tags leadership, clinician-scientist, precision oncology.
- PersonTakayuki Yoshino
Shares the tags leadership, clinician-scientist, precision oncology.
- PersonTony S. K. Mok
Shares the tags leadership, clinician-scientist, precision oncology.